AstraZeneca ($AZN) will make another big investment into its Macclesfield site in Northwest England, its second-largest manufacturing facility and its key site for packaging, although no new jobs are in the offing.
The drugmaker says it will invest £75 million ($113 million) to add to a packaging facility and warehouse, reports the BBC, which says the investment is expected to secure the future of the site's 3,500 employees. The company is in the process of tearing down an old warehouse, and work on the new facilities is slated to begin next month, the news service said.
Two years ago the company laid out plans to add an aseptic drug manufacturing facility at its Macclesfield site, with plans to add three dozen jobs. But that was a fraction of the 1,600 jobs lost from the area when the company moved its R&D operations from Alderley to Cambridge, U.K.
The expansion in Macclesfield was announced a week after it acknowledged it will close an API plant in Bangalore, India, that Swedish regulators have cited with two dozen infractions having to do with the asthma drug API terbutaline sulfate.
- read the BBC story